This patient developed MSSA bacteremia, and it was possible that he experienced an abnormal immune response to the complex of bacteria and PF4 and produced anti-heparin/PF4 antibodies due to enhanced SLE activity. The gene discussed is PF4; the disease is systemic lupus erythematosus.